drugset / Trial / NCT00023985
Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer
Treatment
Summary
RATIONALE: Vaccines made from a person's tumor cells and white blood cells may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have non-small cell lung cancer.
Timeline
- Start
- 2001-01
- Primary completion
- 2003-07
- Completion
- 2003-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous tumor cell vaccine | Vaccine | — | Subcutaneous |
| Subject | therapeutic autologous dendritic cells | Vaccine | — | Subcutaneous |